Finance

Notable Gainers: Navigator Holdings (NYSE:NVGS), Elizabeth Arden (NASDAQ:RDEN), Unilife Corp (NASDAQ:UNIS), X T L Biopharmaceuticals (NASDAQ:XTLB)

Navigator Holdings Ltd (NYSE:NVGS) has exercised options to build three 35,000 cu m LPG carriers at a price tag of $78.4m each at China’s Jiangnan Shipyard. The three newbuildings are on top of one sister vessel already under construction at the Chinese yard. Navigator Holdings Ltd (NYSE:NVGS) stock performance was 11.82% in last session and finished the day at $26.97. Traded volume was 1.94million shares in the last session and the average volume of the stock remained 235.90K shares. The beta of the stock remained 0.08.

LG Household & Health Care Ltd. (051900), a South Korean cosmetics and beverages company, is considering a bid for fragrance maker Elizabeth Arden Inc. (NASDAQ:RDEN) as it looks to expand locally and overseas by buying rivals. Elizabeth Arden, Inc. (NASDAQ:RDEN) rose 11.92 percent to $31.83 Wednesday on volume of 1.10million shares. The intra-day range of the stock was $31.00 to $33.30. Elizabeth Arden, Inc. (NASDAQ:RDEN) has a market capitalization of $945.14million.

Unilife Corporation (NASDAQ:UNIS) has issued a response to a series of articles published against the company this week. Unilife Corporation (NASDAQ:UNIS) said no officer has sold stock since the company listed in 2010 and that both the CEO and COO have purchased in excess of $4 million in stock in recent years. Unilife Corporation (NASDAQ:UNIS)’s stock on Apr 23, 2014 reported a increase of 12.23% to the closing price of $3.58. Its fifty two weeks range is $1.80 -$5.80. The total market capitalization recorded $367.50million. The overall volume in the last trading session was 1.71million shares. In its share capital, UNIS has 102.66million outstanding shares.

X T L Biopharmaceuticals Ltd (ADR) (NASDAQ:XTLB), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced its financial and operational results for the year ended December 31, 2013. On Wednesday, shares of X T L Biopharmaceuticals Ltd (ADR) (NASDAQ:XTLB) advanced 12.90% to close the day at $3.85.